Viewing Study NCT03946358


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-10 @ 6:39 PM
Study NCT ID: NCT03946358
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2019-05-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma of the Head and Neck View
None Anal Canal Cancer View
None Cervical Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human PapillomaVirus (HPV) View
None Atezolizumab View
None Cancer vaccine View
None Cancer immunotherapy View
None Telomerase View